NATCOPHARM.BONATCOPHARM.BOBSE
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank36
3Y CAGR+2.7%
5Y CAGR+11.7%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+2.7%/yr
vs -19.9%/yr prior
5Y CAGR
+11.7%/yr
Recent deceleration
Acceleration
+22.6pp
Accelerating
Percentile
P36
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 11.98% |
| 2024 | 13.25% |
| 2023 | -5.43% |
| 2022 | 11.05% |
| 2021 | -5.59% |
| 2020 | 6.90% |
| 2019 | 30.51% |
| 2018 | 26.83% |
| 2017 | 40.67% |
| 2016 | 50.32% |